The STX7 antibody is a tool used to detect Syntaxin 7. a member of the SNARE (Soluble NSF Attachment Protein Receptor) protein family involved in intracellular membrane trafficking and fusion. Syntaxin 7 localizes primarily to late endosomes and lysosomes, where it facilitates vesicle docking and cargo transport, particularly in endocytic and autophagic pathways. Research on STX7 has highlighted its role in organelle maturation, phagosome-lysosome fusion, and autophagy, processes critical for cellular homeostasis and immune responses.
Antibodies targeting STX7 are widely employed in studies investigating membrane dynamics, vesicle trafficking, and lysosomal function. They enable detection of Syntaxin 7 expression levels, subcellular localization, and interactions via techniques like Western blotting, immunofluorescence, and immunoprecipitation. These applications are pivotal in understanding pathologies linked to trafficking defects, such as neurodegenerative diseases, cancer, and immune disorders.
STX7 antibodies are often validated in models ranging from mammalian cell lines to knockout organisms to ensure specificity. Recent studies also explore STX7's involvement in infection mechanisms, as pathogens may exploit host trafficking machinery. Despite its established roles, ongoing research aims to clarify its regulatory mechanisms and tissue-specific functions, underscoring the antibody's continued relevance in cell biology and translational research.